TVTommaso Viva

Tommaso Viva

*This is an algorithmically generated author record based on publicly available information.

Tommaso Viva has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Patrizio Lancellotti

    GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège Hospital , Liège

    4 shared publications
  • Antonio Miceli

    Department of Minimally Invasive Cardiac Surgery, IRCCS Galeazzi-Sant'Ambrogio Hospital, 20157 Milan, Italy

    3 shared publications
  • Daniele Andreini

    Department of Clinical Cardiology and Cardiovascular Imaging, IRCCS Galeazzi-Sant'Ambrogio Hospital , Via Cristina Belgioioso, 173, Milan 20157

    3 shared publications
  • Mattia Glauber

    IRCCS Ospedale Galeazzi-Sant’Ambrogio, Milan, Italy

    3 shared publications
  • Patrizio Lancellotti

    Department of Cardiology, University of Liège Hospital, GIGA Institutes, CHU Sart Tilman, Sart Tilman

    3 shared publications
  • Arturo Bisogno

    Department of Minimally Invasive Cardiac Surgery, IRCCS Galeazzi-Sant'Ambrogio Hospital, 20157 Milan, Italy

    2 shared publications

Latest Publications

  • Open Access

    The clinical value of left ventricular strain to predict ventricular arrhythmias in mitral valve prolapse: a systematic review and meta-analysis

    by Simona Sperlongano, Tommaso Viva, Vito D Bruno, Giovanni Benfari, Antonello D’ANdrea, Elisabetta Moscarella, Giulia E Mandoli, Felice Gragnano, Arturo Cesaro, Raluca E Dulgheru, et al.

    Arrhythmic risk stratification in patients with mitral valve prolapse (MVP) is still challenging. This systematic review and meta-analysis aimed to analyse the association between echocardiographic strain parameters and ventricular arrhythmias (VAs) in MVP. Studies enlisting MVP patients, in which strain parameters were analysed and a history of significant VAs was reported, were included. The association between myocardial deformation parameters and the occurrence of significant VAs was assessed, and strain parameters were compared between patients with significant VAs [‘arrhythmogenic mitral valve prolapse' (AMVP)] vs. no VAs [‘non-arrhythmogenic mitral valve prolapse’ (NAMVP)]. Seven observational studies (1065 MVP patients) were included. Mechanical dispersion (MD) and post-systolic index (PSI) were associated with significant VAs (MD OR = 1.05, 95% CI 1.01-1.09, P < 0.01; PSI OR = 1.13, 95% CI 1.03-1.23, P < 0.01). AMVP patients showed higher MD and PSI than NAMVP patients (MD mean difference = 7.78 ms, 95% CI 2.81-12.75, P < 0.01; PSI mean difference = 1.12%, 95% CI 0.53-1.72, P < 0.01). Global longitudinal strain (GLS) was associated with VAs in a two-study analysis (OR = 1.16, 95% CI 1.02-1.33, P = 0.03) and was slightly higher in AMVP (mean difference = 1.24%, 95% CI 0.33-2.15, P < 0.01). MD and PSI, and to a lesser extent GLS, were associated with VAs in MVP, and differed between AMVP and NAMVP. These findings are hypothesis generating and require validation in prospective studies before clinical application.

  • The long journey of TAVR: from procedural feasibility to integrated clinical and biomechanical predictors of complications

    by Tommaso Viva, Patrizio Lancellotti

    The indications for transcatheter aortic valve replacement (TAVR) have progressively evolved over time. Initially indicated only for inoperable, high-risk, and elderly patients, TAVR has become a s...


  • Open Access

    Advanced 3D Echocardiographic Assessment of the Aortic Valve and Aortic Root Complex: A Repair-Oriented Perspective

    by Tommaso Viva, Corrado Fiore, Raluca Dulgheru, Daniele Andreini, Mattia Glauber, Patrizio Lancellotti

    The aortic valve (AV) and aortic root complex constitute a functional unit, and their integrated anatomical and dynamic assessment is essential for the management of AV disease. Owing to close collaboration with cardiac surgeons, three-dimensional echocardiography (3DE) has significantly expanded the diagnostic information provided by imaging cardiologists and has a key role in guiding therapeutic strategies. This is particularly relevant in patients with significant aortic regurgitation (AR) undergoing evaluation for valve repair or valve-sparing procedures. Detailed anatomical assessment of the cusps allows characterization of valve morphology and tissue quality, while multiplanar reconstruction enables accurate measurement of key structures, including the virtual basal ring and coronary ostial height. In addition, quantitative assessment of cusp geometry (effective, geometric, and coaptation height) permits precise identification of AR mechanisms, which is critical for guiding repair strategies and selecting appropriate surgical approach. In aortic stenosis (AS), 3DE contributes to the evaluation of discordant or borderline cases by improving left ventricular outflow tract assessment and allowing direct planimetric measurement of the AV area. Furthermore, 3DE provides complementary information in procedural planning for both transcatheter and surgical AV replacement, playing a particularly important role in patients with contraindications to computed tomography. Overall, 3DE, particularly in the transoesophageal setting, has become an essential imaging modality for integrating anatomical and functional information, thereby improving diagnostic accuracy and supporting a repair-oriented approach to tailored treatment in AR.

  • Direct oral anticoagulants versus vitamin K antagonists after heart valve bioprosthetic replacement or repair: A systematic review and meta-analysis

    by Vito D. Bruno, Tom Lester, Enrico Poletti, Bleri Celmeta, Tommaso Viva, Arturo Bisogno, Antonio Miceli, Mattia Glauber

  • Evaluation of three-dimensional right ventricular function and reverse remodelling in patients undergoing percutaneous mitral valve repair for functional mitral regurgitation: insights from a multicentre Italian registry

    by Tommaso Viva, Jessica Zannoni, Antonio Popolo Rubbio, Laura Lupi, Eustachio Agricola, Elena Biagini, Marianna Adamo, Cristina Giannini, Alessandra Berardini, Salvatore Scandura, et al.

    The predictive role of right ventricular dysfunction (RVD) in patients with functional mitral regurgitation (FMR) undergoing transcatheter edge-to-edge repair (TEER), as well as RV remodelling following the procedure, remains uncertain. We evaluated the prognostic impact of pre-procedural three-dimensional (3D) right ventricular ejection fraction (RVEF) in patients with FMR. Additionally, we assessed the RV reverse remodelling (RVRR) based on 3D volumes and ejection fraction six months after the procedure. Data from 74 patients treated with TEER for FMR were prospectively collected. Pre-procedural RVD, defined as 3D RVEF ≤45%, was observed in 47 patients (63.5%). Patients were divided into three groups according to pre-procedural 3D-RVEF: no RVD (No-RVD, RVEF >45%, n = 27), mild-to-moderate RVD (MRVD, RVEF 31-45%, n = 36), and severe RVD (SRVD, RVEF ≤30%, n = 11). Patients with SRVD demonstrated a significant higher rate of all-cause mortality compared with the other two groups (p = 0.04) and RVEF ≤ 30% was associated with all-cause death, independently of left ventricular ejection fraction (LVEF) and left atrial volume index (LAVi) (HR: 3.72, 95% CI 1.12-12.30, p = 0.03). At 6-month follow-up, only patients with pre-procedural MRVD showed a significant reduction in 3D RV volumes and an improvement in RVEF compared to baseline (p < 0.05). RVD was common among patients undergoing mitral TEER for FMR. Those with pre-procedural SRVD had worse mid-term survival compared to patients with MRVD and No-RVD. The group with MRVD was the only one to demonstrate an RVRR six months after the procedure.


  • Open Access

    Three-dimensional assessment of the mitral valve in clinical practice

    by Tommaso Viva, Corrado Fiore, Patrizio Lancellotti

    Three-dimensional echocardiography (3DE), via both transthoracic and transoesophageal approaches, has become an essential tool in the assessment of mitral valve (MV) disease, providing detailed anatomical and functional insights fundamental to both diagnosis and therapeutic planning. By offering a unique volumetric perspective, 3DE allows a comprehensive visualization of the entire MV apparatus, enhancing the capacity to appreciate anatomical and functional details. In mitral regurgitation (MR), 3DE adds pivotal information about leaflet morphology, annular geometry, and sub-valvular structures across all Carpentier subtypes, playing a central role in surgical and percutaneous procedural planning. 3D colour-mode imaging improves spatial localization of regurgitant jets and enables advanced MR quantification techniques. Specifically, 3D proximal isovelocity surface area and 3D vena contracta area offer improved accuracy over 2D methods, particularly in functional MR, and in multiple or complex jets. Additionally, the 3D indirect volumetric method and emerging semi-automated software are further tools for MR quantification. In mitral stenosis, 3D planimetry via transthoracic and transoesophageal echocardiography provides more accurate and reproducible measurements of the MV area compared with 2D, especially in challenging anatomies or suboptimal imaging planes. 3DE, especially using the transoesophageal approach, also improves commissural evaluation, which is essential for patient selection for percutaneous valvuloplasty. Overall, 3DE has redefined MV imaging by offering unparalleled anatomical and quantitative assessment. Its integration into routine clinical practice is critical for modern echocardiography and should be considered a core competency for cardiovascular imaging specialists.


  • Open Access

    Artificial intelligence in the diagnosis and management planning of bicuspid aortic valvular disease: a case series

    by Tommaso Viva, Alessandro Masini, Michele Gallazzi, Vito Domenico Bruno, Antonio Miceli, Mattia Glauber, Daniele Andreini, Edoardo Conte

    Background: Bicuspid aortic valve (BAV) is the most common congenital heart anomaly, often leading to significant aortic stenosis (AS) or aortic regurgitation (AR), which may require surgical intervention. Echocardiography is typically used for the diagnosis of BAV, and the integration of artificial intelligence (AI) can enhance diagnostic accuracy and guide surgical decisions. Case Summary: We present two patients with BAV: a 17-year-old male football player with isolated AR due to prolapse undergoing aortic valve repair, and a 68-year-old male with combined AS and AR, candidate for aortic valve replacement. AI-based tools assisted in characterizing the valvular disease and assessing its hemodynamic impact by estimating and averaging transvalvular gradients and velocity-time-integrals, reconstructing three-dimensional (3D) valve anatomy, and automatically calculating left ventricular volumes, ejection fraction (EF), and global longitudinal strain (GLS). This comprehensive assessment improved prognostic evaluation and helped tailor the treatment plan. Conclusion: AI in echocardiography holds great potential for diagnosis and planning the treatment of BAV disease. By enhancing image analysis and automating key diagnostic steps, AI can reduce diagnostic times and optimize patient outcomes. As AI-based tools continue to evolve and gain clinical validation, their integration into everyday practice will likely lead to a more efficient and accurate care for patients with valvular heart disease.


  • Staging cardiac damage in aortic stenosis: stratifying prognosis to individualise the treatment

    by Tommaso Viva, Simona Sperlongano, Mai-Linh Nguyen Trung, Hélène Petitjean, Patrizio Lancellotti


  • Open Access

    A Risk Prediction Model for Prolonged Length of Stay After Minimally Invasive Valve Surgery

    by Vito D. Bruno, Bleri Celmeta, Tommaso Viva, Arturo Bisogno, Antonio Miceli, Mattia Glauber

    Objective: Minimally invasive surgery determines shorter postoperative hospital length of stay (LOS) even in cardiac surgery. Potential preoperative factors affecting LOS are still not known in minimally invasive heart valve surgery (MIVS). We aimed to identify preoperative variables influencing prolonged LOS in MIVS. Methods: We reviewed 189 patients who underwent MIVS via minithoracotomy at our institution. Prolonged LOS was defined as more than 7 postoperative days. Poisson and logistic regression were used to screen the predictors. Results: The mean postoperative LOS was 9.13 days, and 64 patients (33.9%) experienced a prolonged LOS. These patients were older, more frequently in New York Heart Association (NYHA) class III or IV, showed worse left ventricular ejection function (LVEF), and had a higher incidence of reoperation and chronic kidney disease (CKD). At univariate analysis, the most significant preoperative factors affecting prolonged LOS were age (odds ratio [OR] = 1.04), NYHA class III or IV (OR = 3.03), reduced LVEF (OR = 3.22), CKD (OR = 2.7), and redo surgery (OR = 3.6). After adjustment, the most significant preoperative factors predicting prolonged LOS were age (OR = 1.03, 95% CI: 1.01 to 1.06, P = 0.02) and redo surgery (OR = 3.33, 95% CI: 1.29 to 8.9, P = 0.01). Conclusions: The most important factors affecting prolonged LOS after MIVS were represented by age and redo surgery, although other preoperative characteristics such as reduced LVEF, NYHA class III or IV, and CKD play a significant role in delaying recovery after MIVS. Further larger studies are needed to better identify potential preoperative predictors of prolonged LOS after MIVS.


  • Left atrial strain in acute heart failure: clinical and prognostic insights

    by Monica Barki, Maurizio Losito, Michela Maria Caracciolo, Tadafumi Sugimoto, Marina Rovida, Tommaso Viva, Roberto Arosio, Eleonora Alfonzetti, Francesco Bandera, Alice Moroni, et al.

    Aims: In acute heart failure (AHF), the consequences of impaired left atrial (LA) mechanics are not well understood. We aimed to define the clinical trajectory of LA mechanics by left atrial strain (LAS) analysis. Methods and results: Eighty-five consecutive AHF patients with reduced, mildly reduced, and preserved left ventricular ejection fraction (LVEF) were enrolled in the LAS-AHF trial and underwent LA mechanics analysis by speckle tracking echocardiography. Seventy-seven patients were followed-up (FU) at 6 and 12 months. At hospital admission, discharge, 6 and 12 months post-discharge, LA reservoir function (LAS), LA pump strain, LAVi, LA stiffness, indicators of right ventricular (RV) and left ventricular (LV) function, congestion indexes (B lines, inferior vena cava, X-ray congestion score index), and biomarkers (NT-pro-BNP) were measured. The primary outcome was time to first event of re-hospitalization, worsening HF, or cardiovascular death. From admission to discharge, RV function significantly improved after decongestion, whereas no significant differences were observed in LA dynamics and LV function. In sinus rhythm patients with mild or no mitral regurgitation, decongestion was associated with a significant improvement of LAS and LA pump strain rate during hospitalization. At 12 months, 24 CV events occurred and lack of LAS improvement at 12 months FU emerged as the most powerful predictor followed by NT-pro-BNP. Kaplan–Meier curves showed a better survival for LAS >16%, improvement of LAS > 5%, and an LAS/LAVi ratio >0.25%/mL/m2 compared with lower cut-off values [log-rank: heart rate (HR) 3.5, 95% confidence interval (CI) 1.8–7.3, P = 0.004; log-rank: HR 3.6, 95% CI 2–7.9, P < 0.01; log-rank: HR 3.27, 95% CI 1.4–7.7, P = 0.007]. Conclusion: In AHF of any LVEF, LA dynamics is highly predictive of re-hospitalization and cardiovascular outcome and allows to ease risk-stratification, potentially becoming an early reference target for improving long-term outcome.